Status:
COMPLETED
Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study
Lead Sponsor:
AstraZeneca
Conditions:
Rosuvastatin
Heart Failure
Eligibility:
All Genders
60+ years
Phase:
PHASE3
Brief Summary
At one site, patients participating in the Corona main study are asked to participate in the PET-substudy. Before and 6 months after study medication is started a Positron Emission Tomography (PET-sca...
Eligibility Criteria
Inclusion
- Patients fulfilling the in and exclusion criteria of the CORONA study and separate informed consent for participation in the sub study.
Exclusion
- See above
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
End Date :
July 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00228514
Start Date
February 1 2004
End Date
July 1 2007
Last Update
November 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Groningen, Netherlands